China’s aggressive drive to replace brand-name foreign drugs with dirt-cheap homegrown generics has already taken a toll on ...
includes everything from aspirin to certain cancer drugs. The implications of this slowdown in research and development could be disastrous for patients. These price controls are the heart of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results